Phase 3 Study to Evaluate the Efficacy and Safety of Therapy as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease

August 22, 2018
https://clinicaltrials.gov/ct2/show/NCT02394028
Gastroenterology Hepatology
Principal Investigator: Nirmal Kaur, MD
crohn's disease, Crohn's disease, Crohn's, crohns, IBD
Open